Jobs / United States / Glaxosmithkline LLC
Director, Market Access Strategy, Access Optimization Lead (Oncology)
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Job Description Location: Philly or Durham. Must be onsite 2-3 days per week. Reporting to the Senior Director, Market Access Strategy, Oncology Portfolio Lead, the Director, Oncology Market Access Strategy – Access Optimization Lead serves as the enterprise market access leader for assigned oncology brand(s) and indications. This role is responsible for shaping and leading the integrated market access strategy across payer, provider, patient access, pricing and contracting, trade and distribution, and health system channels to maximize brand performance and patient access. This leader acts as the primary market access partner to the brand, serving as a core member of the Integrated Brand Commercialization Team (IBCT) and helping define the strategic choices required to win in a complex and evolving oncology environment. The role is accountable for translating market dynamics, customer insights, competitive intelligence, reimbursement realities, and financial tradeoffs into a clear near-, mid-, and long-term access strategy for the brand. The Director partners across pricing and contracting, account teams, patient experience, trade and distribution, access marketing, access analytics, HEOR / value evidence, finance, policy, medical, and brand teams to align on the integrated strategic plan and ensure execution against the most critical access priorities. Success in this role requires strong strategic leadership, deep oncology market access expertise, and the ability to influence senior stakeholders across a matrixed organization. This position is ideal for a strategic leader who can operate as a peer to brand leadership while bringing a distinct market access lens to brand strategy, launch planning, lifecycle management, and performance optimization. Key Responsibilities • Serve as the market access strategy lead for assigned oncology brand(s), accountable for the integrated access strategy across payer, provider, patient support, pricing/contracting, trade/distribution, and organized customer segments. • Act as the primary Market Access representative on the IBCT , shaping brand strategy and ensuring access considerations are embedded in core commercial decisions, launch plans, lifecycle planning, and performance discussions. • Develop and own the near-, mid-, and long-term market access strategy , including strategic choices required to optimize access, brand growth, financial performance, and customer pull-through. • Lead the development of the brand’s access perspective within the integrated brand plan , annual operating plan, and long-range strategic planning. • Translate customer, competitor, policy, reimbursement, and market signals into actionable recommendations that evolve the value proposition, evidence needs, strategic priorities, and tactical plan. • Partner with pricing and contracting, analytics, HEOR, patient experience, account teams, and trade/channel teams to evaluate choiceful tradeoffs across investments, GTN implications, customer strategies, and launch/lifecycle priorities. • Shape the oncology access journey for the brand, identifying critical barriers and opportunities across coverage, coding, reimbursement, affordability, site of care, channel strategy, and patient support. • Lead cross-functional alignment around access strategy and ensure the broader market access matrix is coordinated against the most important business priorities. • Provide clear and timely access guidance to brand and senior leadership on competitive events, reimbursement changes, payer and provider dynamics, organized customer trends, and emerging risks/opportunities. • Inform the development of customer-facing resources, evidence communication, segment strategies, and field guidance to ensure the market access strate